Servizo
Oncoloxía médica
Publicacións (38) Publicacións nas que participase algún/ha investigador/a
2010
-
A functional role of RB-dependent pathway in the control of quiescence in adult epidermal stem cells revealed by genomic profiling
Stem Cell Reviews and Reports, Vol. 6, Núm. 2, pp. 162-177
-
A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer
British Journal of Cancer, Vol. 103, Núm. 10, pp. 1536-1541
-
Abdomen agudo e ingesta de cuerpos extraños: revisión de seis casos
Galicia Clínica, Vol. 71, Núm. 3, pp. 117-120
-
Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: A phase 2 study (SOGUG-02-06)
The Lancet Oncology, Vol. 11, Núm. 4, pp. 350-357
-
Adjuvant docetaxel for high-risk, node-negative breast cancer
New England Journal of Medicine, Vol. 363, Núm. 23, pp. 2200-2210
-
Adult stem cells and their relationship with cancer
Cancer and Chemotherapy Reviews, Vol. 5, Núm. 2, pp. 75-81
-
Anemia response and safety to epoetin-beta treatment in patients with neoadjuvant therapy prior to primary digestive tract tumor surgery
Cancer Chemotherapy and Pharmacology, Vol. 66, Núm. 3, pp. 567-573
-
Artropatía neuropática del hombro por siringomielia
Medicina Clinica, Vol. 135, Núm. 1, pp. 45
-
Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing Spondylitis
Arthritis and Rheumatism, Vol. 62, Núm. 4, pp. 1000-1006
-
Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
British Journal of Cancer, Vol. 102, Núm. 10, pp. 1468-1473
-
Cetuximab given every 2 weeks plus irinotecan is an active and safe option for previously treated patients with metastatic colorectal cancer
Chemotherapy, Vol. 56, Núm. 2, pp. 142-146
-
Colorectal cancer prognosis twenty years later
World Journal of Gastroenterology, Vol. 16, Núm. 7, pp. 862-867
-
Current controversies in the management of breast cancer
Clinical and Translational Oncology, Vol. 12, Núm. 4, pp. 278-286
-
Cáncer de ovario. Enfermedad platino resistente
Revisiones en Cancer, Vol. 24, Núm. 6, pp. 253-262
-
Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer
Journal of Translational Medicine, Vol. 8
-
Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection
Journal of Virology, Vol. 84, Núm. 1, pp. 475-481
-
Efficacy of epoetin-beta 30,000 IU/week in correcting anaemia in patients with gastrointestinal tumours subjected to concomitant chemoradiotherapy
Clinical and Translational Oncology, Vol. 12, Núm. 12, pp. 843-848
-
Enfermedad de Rendu-Osler con afectación hepática: primer trasplante en España
Medicina Clinica, Vol. 135, Núm. 12, pp. 552-555
-
Evaluation of COX-2, EGFR, and p53 as biomarkers of non-dysplastic oral leukoplakias
Experimental and Molecular Pathology, Vol. 89, Núm. 2, pp. 197-203
-
Evaluation of Plakophilin-3 mRNA as a biomarker for detection of circulating tumor cells in gastrointestinal cancer patients
Cancer Epidemiology Biomarkers and Prevention, Vol. 19, Núm. 6, pp. 1432-1440